These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11925470)

  • 21. [The expression of cholecystokinin-octapeptide receptor in vascular endothelial cells induced by lipopolysaccharide].
    Ping J; Gu ZY; Gao F; Cong B; Ling YL
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Sep; 21(9):548-51. PubMed ID: 19751565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of cholecystokinin 2 receptor in food intake regulation: hyperphagia and increased fat deposition in cholecystokinin 2 receptor-deficient mice.
    Clerc P; Coll Constans MG; Lulka H; Broussaud S; Guigné C; Leung-Theung-Long S; Perrin C; Knauf C; Carpéné C; Pénicaud L; Seva C; Burcelin R; Valet P; Fourmy D; Dufresne M
    Endocrinology; 2007 Mar; 148(3):1039-49. PubMed ID: 17122076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin.
    Gigoux V; Maigret B; Escrieut C; Silvente-Poirot S; Bouisson M; Fehrentz JA; Moroder L; Gully D; Martinez J; Vaysse N; Fourmy AD
    Protein Sci; 1999 Nov; 8(11):2347-54. PubMed ID: 10595537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotypes of mice with invalidation of cholecystokinin (CCK(1) or CCK(2)) receptors.
    Noble F; Roques BP
    Neuropeptides; 2002; 36(2-3):157-70. PubMed ID: 12359506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of lipopolysaccharide on expression and characterization of cholecystokinin receptors in rat pulmonary interstitial macrophages.
    Xu SJ; Gao WJ; Cong B; Yao YX; Gu ZY
    Acta Pharmacol Sin; 2004 Oct; 25(10):1347-53. PubMed ID: 15456538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
    Béhé M; Behr TM
    Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deficits in E2-dependent control of feeding, weight gain, and cholecystokinin satiation in ER-alpha null mice.
    Geary N; Asarian L; Korach KS; Pfaff DW; Ogawa S
    Endocrinology; 2001 Nov; 142(11):4751-7. PubMed ID: 11606440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight.
    Kopin AS; Mathes WF; McBride EW; Nguyen M; Al-Haider W; Schmitz F; Bonner-Weir S; Kanarek R; Beinborn M
    J Clin Invest; 1999 Feb; 103(3):383-91. PubMed ID: 9927499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholecystokinin-B/Gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies.
    Behr TM; Béhé MP
    Semin Nucl Med; 2002 Apr; 32(2):97-109. PubMed ID: 11965605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of cholecystokinin A receptor gene polymorphism with cholelithiasis and the molecular mechanisms of this polymorphism.
    Miyasaka K; Takata Y; Funakoshi A
    J Gastroenterol; 2002 Nov; 37 Suppl 14():102-6. PubMed ID: 12572876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular effects of cholecystokinin-4 are mediated by the cholecystokinin-B receptor subtype in the conscious guinea pig and dog.
    Fossa AA; DePasquale MJ; Morrone J; Zorn SH; Bryce D; Lowe JA; McLean S
    J Pharmacol Exp Ther; 1997 Apr; 281(1):180-7. PubMed ID: 9103496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholecystokinin2 receptor-deficient mice display altered function of brain dopaminergic system.
    Kõks S; Volke V; Veraksits A; Rünkorg K; Sillat T; Abramov U; Bourin M; Huotari M; Männistö PT; Matsui T; Vasar E
    Psychopharmacology (Berl); 2001 Nov; 158(2):198-204. PubMed ID: 11702094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreatic secretory response to feeding in the calf: CCK-A receptors, but not CCK-B/gastrin receptors are involved.
    Le Dréan G; Le Huërou-Luron I; Gestin M; Romé V; Bernard C; Chayvialle JA; Fourmy D; Guilloteau P
    Can J Physiol Pharmacol; 2000 Oct; 78(10):813-9. PubMed ID: 11077982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of cholecystokinin-B/gastrin receptor domains that confer high gastrin affinity: utilization of a novel Xenopus laevis cholecystokinin receptor.
    Schmitz F; Pratt DS; Wu MJ; Kolakowski LF; Beinborn M; Kopin AS
    Mol Pharmacol; 1996 Aug; 50(2):436-41. PubMed ID: 8700154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of cholecystokinin and opioid peptides in control of food intake.
    Baile CA; McLaughlin CL; Della-Fera MA
    Physiol Rev; 1986 Jan; 66(1):172-234. PubMed ID: 2868468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted mutation of CCK(2) receptor gene antagonises behavioural changes induced by social isolation in female, but not in male mice.
    Abramov U; Raud S; Kõks S; Innos J; Kurrikoff K; Matsui T; Vasar E
    Behav Brain Res; 2004 Nov; 155(1):1-11. PubMed ID: 15325774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of cholecystokinin in appetite control and body weight regulation.
    Little TJ; Horowitz M; Feinle-Bisset C
    Obes Rev; 2005 Nov; 6(4):297-306. PubMed ID: 16246215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholecystokinin octapeptide analogues suppress food intake via central CCK-A receptors in mice.
    Hirosue Y; Inui A; Teranishi A; Miura M; Nakajima M; Okita M; Nakajima Y; Himori N; Baba S; Kasuga M
    Am J Physiol; 1993 Sep; 265(3 Pt 2):R481-6. PubMed ID: 8214137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholecystokinin-2 (CCK2) receptor-mediated anxiety-like behaviors in rats.
    Wang H; Wong PT; Spiess J; Zhu YZ
    Neurosci Biobehav Rev; 2005; 29(8):1361-73. PubMed ID: 16120463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blockade of type A, not type B, CCK receptors attenuates satiety actions of exogenous and endogenous CCK.
    Moran TH; Ameglio PJ; Schwartz GJ; McHugh PR
    Am J Physiol; 1992 Jan; 262(1 Pt 2):R46-50. PubMed ID: 1733339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.